Insulin resistance dysregulates CYP7B1 leading to oxysterol accumulation: a pathway for NAFL to NASH transition-Reference-Cited by-同舟云学术

Insulin resistance dysregulates CYP7B1 leading to oxysterol accumulation: a pathway for NAFL to NASH transition

Published:2020-12 Issue:12 Volume:61 Page:1629-1644
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Kakiyama Genta,Marques Dalila,Martin Rebecca,Takei Hajime,Rodriguez-Agudo Daniel,LaSalle Sandra A.,Hashiguchi Taishi,Liu Xiaoying,Green Richard,Erickson Sandra,Gil Gregorio,Fuchs Michael,Suzuki Mitsuyoshi,Murai Tsuyoshi,Nittono Hiroshi,Hylemon Phillip B.,Zhou Huiping,Pandak William M.

Funder

Gilead Sciences

U.S. Department of Veterans Affairs

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference70 articles.

1. Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation;Younossi;Transplantation,2019

2. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis;Younossi;Hepatology,2019

3. Natural history of non-alcoholic fatty liver disease: a study with paired liver biopsies;Reddy;J. Clin. Exp. Hepatol.,2020

4. Natural history of simple steatosis or nonalcoholic fatty liver;De;J. Clin. Exp. Hepatol.,2020

5. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement;Eslam;J. Hepatol.,2020

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic estrogen receptor alpha drives masculinization in post-menopausal women with metabolic dysfunction-associated steatotic liver disease;JHEP Reports;2024-10

2. Hepatic IL22RA1 deficiency promotes hepatic steatosis by modulating oxysterol in the liver;Hepatology;2024-07-10

3. StarD5 levels of expression correlate with onset and progression of steatosis and liver fibrosis;American Journal of Physiology-Gastrointestinal and Liver Physiology;2024-06-01

4. Larsucosterol: endogenous epigenetic regulator for treating chronic and acute liver diseases;American Journal of Physiology-Endocrinology and Metabolism;2024-05-01

5. CYP7B1 as a Biomarker for Prostate Cancer Risk and Progression: Metabolic and Oncogenic Signatures (Diagnostic Immunohistochemistry Analysis by Tissue Microarray in Prostate Cancer Patients—Diamond Study);International Journal of Molecular Sciences;2024-04-27